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Although increasing adiposity is usually associated with adipose tissue infiltration by inflammatory cells
and systemic insulin resistance, Stolarczyk et al. (2013) report in this issue that mice deficient in the T-box
transcription factor, T-bet, display a dissociated phenotype with enhanced perigonadal adipose but
enhanced insulin sensitivity.The last decade has witnessed much
progress in characterizing the metabolic
syndrome as a dysregulated state associ-
ated with chronic systemic inflammation
and loss of tissue insulin sensitivity. Not
infrequently, increased nutrient storage
results in focal adipose damage and infil-
tration by inflammatory cells, thus setting
up a feed-forward cycle whereby insulin
insensitivity and adipose tissue inflamma-
tion become locked in a metabolically
nonfunctional state. T-bet was identified
as a transcription factor demonstrated
to play a nonredundant role in the
differentiation of naive CD4 T cells to the
IFN-g-producing Th1 subset (Szabo
et al., 2000). The restricted expression of
T-bet, or Tbx21, to the hematopoietic
system promised a straightforward inter-
rogation of the role for IFN-g-expressing
inflammatory cells in metabolic homeo-
stasis. In this issue of Cell Metabolism,
Stolarczyk et al. reveal a relationship be-
tween inflammation, adiposity, and insulin
insensitivity in T-bet-deficient mice fed a
high-fat diet (Stolarczyk et al., 2013).
Stolarczyk et al. found that T-bet-
deficient mice gained weight on both
regular chow and high-fat diet that could
be attributed to increased perigonadal,
but not subcutaneous, adipose mass.
Despite the increased adiposity, however,
insulin sensitivity was increased, and
this was accompanied by diminished
numbers of hematopoietic cells in perigo-
nadal adipose tissue and a decrease in
cytokines released from adipose tissue
ex vivo. In order to separate contributions
by T-bet in the adaptive and innate im-
mune system, the authors assessed T-
bet-deficient mice on a Rag-deficient
background that lacks T and B cells, but
has persisting NK cells and other innate
lymphoid cells that express T-bet. Here,the absence of T-bet conferred no differ-
ences in body weight, adiposity, or insulin
sensitivity, although the decline in
amounts of IFN-g released fromperigona-
dal adipose tissue persisted, but estab-
lished adaptive immune cells as being
responsible for the phenotype. Adoptive
transfer of T-bet-deficient CD4 T cells
into Rag-deficient mice recapitulated a
partial phenotype: mice showedmodestly
enhanced insulin sensitivity and had
decreased numbers of adipose CD4
T cells. Finally, IFN-g, a known target of
T-bet, was incriminated by the observa-
tion that crossing T-bet- and IFN-g-
deficient mice largely abrogated the
phenotype.
Thus, T-bet deficiency dissociates peri-
gonadal adiposity from insulin sensitivity,
and this is dependent on adaptive immu-
nity and at least partially on CD4 T cells
and IFN-g. As the authors point out,
T-bet-deficient mice had increased
numbers of Foxp3+ regulatory CD4
T cells, or Tregs, in perigondadal adipose
tissue as compared to wild-type mice.
Recent reports have called attention to
Tregs in adipose tissue, where they have
tissue protective and insulin-promoting
effects by virtue of suppressing inflamma-
tory cell accumulation and activation.
Interestingly, adipose Tregs express
genes involved in lipid synthesis and
storage and respond to agonistic PPARg
thiazolidinedione drugs, suggesting these
cells may contribute directly to adipose
storage while suppressing cytokine pro-
duction by immune effector cells (Cipol-
letta et al., 2012). This phenotype mirrors
the phenotype in the T-bet knockout
mice and would be additionally consistent
with the loss of the phenotype upon
crossing to the Rag-deficient back-
ground, which lack all T cells, includingCell MetabolismTregs. This would also explain the partial
reconstitution of the phenotype by adop-
tive transfer of CD4 T cells into Rag-
deficient mice, although the authors do
not examine the numbers of Foxp3+ Tregs
that repopulate the perigonadal adipose
tissue.
A puzzling aspect of the Treg explana-
tion is the IFN-g-dependent nature of the
phenotype. Tregs are suppressor cells
and do not typically produce cytokines
like IFN-g, but the results suggest that
Tregs are reading out IFN-g-dependent
signals necessary for their functional role
inmediating adipose storage and immune
cell suppression. How might this be?
Increasing evidence suggests that
Tregs come in flavors that mirror features
of the effector CD4 helper T cell subsets
they suppress (Chaudhry and Rudensky,
2013). From a simplified mechanistic
point of view, Tregs need to integrate the
same overlapping sets of environmental
cues, including chemokines and cyto-
kines, used by effector T cell subsets in
order to accumulate in the tissues and
immune microenvironments where regu-
lation is needed to suppress otherwise
damaging autoreactive responses under
diverse immunologic conditions. Like T-
bet in Th1 cell differentiation, GATA-3 is
intricately involved in the epigenetic pro-
gramming mediating Th2 development;
evidence for direct interaction of T-bet in
suppressing GATA-3 levels during T cell
differentiation likely contributes to the
biasing of T-bet-deficient cells to express
Th2-associated cytokines under some
conditions (Hwang et al., 2005). Thus, in
the absence of T-bet, GATA-3 expression
is left unrestrained in T cells. Intriguingly,
GATA-3 is highly expressed in adipose
Tregs, where expression correlates
directly with PPARg (Cipolletta et al.,17, April 2, 2013 ª2013 Elsevier Inc. 473
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Previews2012), consistent with the increased
numbers of Foxp3+ adipose Tregs in
T-bet-deficient mice.
So howmight these cells be dependent
upon IFN-g for their metabolic pheno-
type? In naive T cells, IFN-g from other
cells (or IL-27, which shares this capacity)
induces T-bet, which transcriptionally
targets the second chain of the IL-12 re-
ceptor (the first is constitutive), enabling
these cells to use IL-12 to super-induce
IFN-g production through Stat1/Stat4-
facilitated epigenetic reprogramming of
the IFN-g locus. In Tregs, T-bet is ex-
pressed in the first step, but expression
of IL-12Rb2 is not, in part explained by
epigenetic silencing of the locus, thus
depriving Tregs of effector cytokines
while leaving them programmed to sense
inflammatory mediators (Koch et al.,
2012). Such effects may be amplified in
the genetic absence of T-bet. In adipose
tissues, where GATA-3 is highly ex-
pressed in Tregs and more readily
induced in the absence of T-bet, robust
Tregs may facilitate central adipose
storage while suppressing hematopoietic
cell infiltration, as seen by Stolarczyk
et al. In peripheral tissues, residual
IFN-g driven by eomesodermin (Tbr2, a
Tbox21 cousin) in T and NK cells (Pearce
et al., 2003) may be the source of T-bet-
independent signals that sustain Tregs
in a state such that peripheral mani-474 Cell Metabolism 17, April 2, 2013 ª2013festations of inflammation, which can
occur at mucosal sites in T-bet-deficient
mice (Garrett et al., 2007), are abrogated,
thus promoting systemic insulin sensi-
tivity. Indeed, the authors point out that
their immunodeficient mouse colonies
are devoid of the colitogenic microbial
flora that drives inflammation in some of
these knockout mice, perhaps reflecting
a role for T-bet in sustaining mucosa-
protective IL-22-producing innate lym-
phoid cells at the expense of IL-17- and
IFN-g-dependent pathology (Buonocore
et al., 2010), while providing protection
against epithelial pathogens (Klose et al.,
2013). Indeed, when crossed to the T-
bet-deficient background, Rag-deficient
mice lost some but not all IFN-g produc-
tion, revealing a basal state that may be
dependent on the environment in
which the mice are maintained. How
Tregs and ILCs interact is a highly
topical question, and the authors’ model
may provide one system for such
investigation.
The findings of Stolarczyk et al. high-
light the continuing surprises unearthed
in the young field of ‘‘immunometabo-
lism’’ but underscore the need for con-
sideration of the integrative nature of
metabolism in peeling away the multiple
layers of overlying regulation, including
by cells and cytokines, of the immune sys-
tem, both adaptive and innate.Elsevier Inc.REFERENCES
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